Skip to main content
KOMIPHARM INTERNATIONAL CO., LTD. logo

KOMIPHARM INTERNATIONAL CO., LTD. — Investor Relations & Filings

Ticker · 041960 ISIN · KR7041960006 KO Manufacturing
Filings indexed 326 across all filing types
Latest filing 2021-12-22 Regulatory Filings
Country KR South Korea
Listing KO 041960

About KOMIPHARM INTERNATIONAL CO., LTD.

https://komipharm.co.kr/en/

Komipharm International Co., Ltd. is a biopharmaceutical company engaged in the development, manufacturing, and sale of products for both animal and human health. Its Animal Health Division provides a portfolio of veterinary vaccines, pharmaceuticals, and disinfectants. The company's Pharmaceutical Division is dedicated to the research and development of novel therapeutic agents, with key research areas including anticancer drugs and treatments for cancer-related pain and autoimmune diseases. Leveraging extensive experience, the company focuses on intensive R&D to expand its presence in the global bio-industry.

Recent filings

Filing Released Lang Actions
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a formal regulatory disclosure from K-OSDAQ listed company Komipharm regarding a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결). It details the contract value, counterparty (Public Procurement Service), and contract terms. Since this is a specific regulatory disclosure of a material business event that does not fit into the other specialized categories like M&A or financial reports, it falls under the general regulatory filing category.
2021-12-22 Korean
타법인주식및출자증권취득결정
Capital/Financing Update Classification · 95% confidence The document is a formal regulatory disclosure from Komipharm regarding the acquisition of shares in another company (Komipharm International Australia Pty. Ltd). It details the acquisition price, purpose, and financial impact, which is a standard corporate action announcement. Since it involves the acquisition of shares in a subsidiary to improve its financial structure, it falls under the category of capital and financing updates.
2021-12-21 Korean
유상증자결정(종속회사의주요경영사항)
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory announcement regarding a capital increase (paid-in capital increase) by a subsidiary of Komipharm. It details the number of shares, issuance price, purpose of funds, and the board resolution date. This falls under the category of share issuance and capital changes.
2021-12-17 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement from KORAMED regarding the setting of a record date and shareholder register closure period for the purpose of holding an Annual General Meeting. It does not contain the full meeting materials or proxy statements, but rather serves as a formal regulatory notice of the upcoming meeting logistics. Given it is a standard regulatory notification regarding corporate actions, it fits best under the RNS category.
2021-12-16 Korean
투자판단관련주요경영사항(COVID-19 감염 중등증 환자에게 PAX-1(경구용)을 경구투여하는 2개의 코호트 대한 파키스탄 식약처(DRAP) 임상1상 시험계획 신청)
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from a Korean company (Komipharm) regarding a 'Major Management Matter' (투자판단 관련 주요경영사항), specifically the application for a Phase 1 clinical trial for a COVID-19 treatment in Pakistan. This type of disclosure is a standard regulatory announcement for material corporate events in the Korean market. Since it does not fit into specific categories like M&A, dividends, or financial reports, it falls under the general regulatory filing category.
2021-11-25 Korean
분기보고서 (2021.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for Komipharm, covering the period from January 1, 2021, to September 30, 2021. It contains detailed financial statements, management discussion and analysis, and corporate governance information, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2021
2021-11-12 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.